April 26, 2016April 26, 2016

Radiation’s Role in Hodgkin Lymphoma Challenged in Wake of Cancer Recurrence, Toxicity

News

A cover story on Healio.com’s current issue of the online publication HemOnc Today draws attention to the risks associated with radiation treatment for Hodgkin lymphoma — an issue that’s been a ... Read more

October 29, 2015October 29, 2015

Target Enrollment Reached in Phase 3 Trial of ADCETRIS in Select Advanced Hodgkin Lymphomas

News

Bothell, Washington-based Seattle Genetics, Inc. — a biotechnology company focused on development and commercialization of innovative antibody-based therapies for the treatment of cancer — and Takeda Pharmaceutical Company Limited of ... Read more